Only certain cost components relating to COVID-19 services can be reimbursed, including costs associated with administration, accommodation, doctors, use of ventilators, medicine, consumable medical treatments, medical devices including personal protective devices, and so forth

After securing SMKPO certificates, business actors will then be required to: 1) Fulfill the SMKPO standards or commitments within six months of said SMKPO certificates being issued; 2) Possess the SMKPO documents and establish an SMKPO team

Healthcare facilities that offer telemedicine services during the COVID-19 pandemic comprise the following: 1) Hospitals; 2) Public health centers (puskesmas); 3) Clinics; 4) Independent practices of doctors/dentists and specialists/dental specialists; 5) Medical laboratories; and 6) Pharmacies

The business activities encompass the following sub-sectors: 1) Pharmaceuticals, health equipment and household health supplies; 2) Health services; 3) Control over vectors and disease-carrying animals

This Draft Regulation stipulates the standards and requirements that apply across various subsectors of the food and drugs sector, specifically: 1) Drugs; 2) Traditional drugs, quasi-drugs, health supplements and cosmetics; 3) Processed foods; and 4) Imports and exports of food and drugs

All hospitals must provide isolation spaces that can contain a minimum of 10% of the total number of available hospital beds

The Government is aiming to procure COVID-19 vaccines and to subsequently implement a widespread vaccination program during 2020, 2021 and 2022 or across a longer timeframe, as stipulated by the Committee for the Mitigation of COVID-19 and National Economic Recovery

Technical guidance will be implemented in relation to minor findings and/or less than six major findings, while administrative sanctions will be imposed if violations of prevailing laws and regulations are discovered which are not categorized as findings that trigger the implementation of technical guidance

Guidelines for the assessment of human cell-based medicines which are being aimed at distribution within Indonesia encompass technical requirements for the following areas: 1) Risk analysis; 2) Product quality and manufacturing processes; 3) Non-clinical development; 4) Clinical development; and 5) Pharmacovigilance and risk-management planning

The National Agency for Drug and Food Control is currently required to issue approvals/rejections for SKI applications within six hours of complete and compliant applications being received, instead of the one business day that was mandated under the previous regulation.